Studies in older adults have linked variation in MEF2C gene to the risk of multiple neurological disorders, such as Late Onset Alzheimer’s disease (LOAD) and Parkinson’s disease (She et al., 2012; Dietrich, 2013; Davies et al., 2015). This evidence concerns the gene MEF2C and early-onset autosomal dominant Alzheimer disease.